Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-11-02-2002
Volume26
Issue 11

Residual Solvent Analysis in Pharmaceuticals

Author(s):

Anil M. Dwivedi, PhD

The author discusses the current pharmacopeial status of the acceptance limits and classifications of pharmaceutical residual solvents.

External Link - article-38267.pdf

Articles in this issue
Contract Services
Major Changes Ahead for FDA
Estimation of Distribution Coefficients from the Partition Coefficient and pKa
Residual Solvent Analysis in Pharmaceuticals
Preparation and In Vitro Evaluation of Miconazole Nitrate-Loaded Topical Liposomes

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave A Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, CSO, AustinPx
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 15th 2025

FDA Commissioner Applauds Florida Restriction on 7-OH Opioids

Susan Haigney
Drug Solutions Podcast: Sustainable Solutions for Biopharma
August 15th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
Site Logo
August 15th 2025

Decentralized Trials: The Value of Direct-to-Patient & Pharmacy-Led Solutions

Catalent
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
August 15th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
Site Logo
August 15th 2025

European Clinical Supply Planning – Balancing Cost, Flexibility & Time

Catalent
Site Logo
August 15th 2025

Optimizing Clinical Trials in China with Strategic Solutions for Supply Chain Challenges

Catalent